ENTOS
LIVE

Serial Number

88930350

Owner

ENTOS PHARMACEUTICALS INC.

Attorney

Theodore R. Remaklus

First Use Date

Oct 3, 2019

Filing Date

May 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ENTOS Trademark

Serial Number: 88930350 • Registration: 6414416

ENTOS is a trademark filed by ENTOS PHARMACEUTICALS INC. on May 22, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ENTOS PHARMACEUTICALS INC. (9 trademarks)

10230 JASPER AVENUE, UNIT 4550
EDMONTON, AB T5J4P6 , CA

Entity Type: 03

Entos, Inc. (4 trademarks)

Los Angeles, CA 90027

Entity Type: 03

Trademark Details

Filing Date

May 22, 2020

Registration Date

July 13, 2021

First Use Anywhere

October 3, 2019

First Use in Commerce

October 3, 2019

Published for Opposition

April 27, 2021

Goods & Services

Downloadable software for optimizing the development and discovering of new and existing molecules, drugs, and batteries, all for use in the field of computer science, chemistry, biochemistry, physics, chemical engineering, and biology; downloadable software applications for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products; customized downloadable computer software using artificial intelligence and machine learning to provide bespoke digital simulations in the fields of chemistry, physics, biology, biochemistry, computer science, and chemical engineering

Scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 4, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 4, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2025 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 8, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 8, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 8, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 8, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 8, 2023 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 3, 2023 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 8, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 8, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Jul 13, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2020 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 12, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 12, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 12, 2020 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2020 NWOS
NEW APPLICATION ENTERED
May 26, 2020 NWAP